VTRS
Viatris Inc
NASDAQ: VTRS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$14.94
-0.20% today
Updated 2026-04-30
Market cap
$17.43B
P/E ratio
—
P/S ratio
1.22x
EPS (TTM)
$-3.00
Dividend yield
3.24%
52W range
$8 – $16
Volume
10.5M
WallStSmart proprietary scores
50
out of 100
Grade: C
Hold
Investment rating
3.3
Growth
D4.5
Quality
C3.5
Profitability
D8.3
Valuation
A4/9
Piotroski F-Score
Moderate
0.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$15.72
+5.22%
12-Month target
—
—
Intrinsic (DCF)
$23.77
Margin of safety
+32.14%
1 Strong Buy5 Buy4 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $550.50M — positive
+ 32.14% below intrinsic value
Risks
- Altman Z 0.80 — distress zone
- Thin margins at -24.60%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $16.26B | $15.43B | $14.74B | $14.30B | $14.30B |
| Net income | $2.08B | $54.70M | $-634.20M | $-3.51B | $-340.10M |
| EPS | — | — | — | — | $-3.00 |
| Free cash flow | $2.51B | $2.33B | $1.98B | $1.94B | $550.50M |
| Profit margin | 12.78% | 0.35% | -4.30% | -24.58% | -24.60% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-15 | LE, GOFF CORINNE | Sale | 39,344 | — |
| 2026-04-15 | LE, GOFF CORINNE | Sale | 3,644 | — |
| 2026-04-15 | LE, GOFF CORINNE | Buy | 39,344 | — |
Peer comparison
Smart narrative
Viatris Inc trades at $14.94. Our Smart Value Score of 50/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.80, it sits in the distress. TTM revenue stands at $14.30B. with profit margins at -24.60%. Our DCF model estimates intrinsic value at $23.77.
Frequently asked questions
What is Viatris Inc's stock price?
Viatris Inc (VTRS) trades at $14.94.
Is Viatris Inc overvalued?
Smart Value Score 50/100 (Grade C, Hold). DCF value $23.77.
What is the price target of Viatris Inc (VTRS)?
The analyst target price is $15.72, representing +5.2% upside from the current price of $14.94.
What is the intrinsic value of Viatris Inc (VTRS)?
Based on our DCF model, intrinsic value is $23.77, a +32.1% margin of safety versus $14.94.
What is Viatris Inc's revenue?
TTM revenue is $14.30B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
0.80 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.22x
ROE-21.10%
Beta0.82
50D MA$14.26
200D MA$11.83
Shares out1.16B
Float1.14B
Short ratio—
Avg volume10.5M
Performance
1 week+2.40%
1 month+9.61%
3 months+14.13%
YTD+20.00%
1 year—
3 years—
5 years—